These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8603402)
1. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Rea D; Parker MG Cancer Res; 1996 Apr; 56(7):1556-63. PubMed ID: 8603402 [TBL] [Abstract][Full Text] [Related]
2. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Castles CG; Fuqua SA; Klotz DM; Hill SM Cancer Res; 1993 Dec; 53(24):5934-9. PubMed ID: 8261406 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Pfeffer U; Fecarotta E; Castagnetta L; Vidali G Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651 [TBL] [Abstract][Full Text] [Related]
4. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Morrissey JJ; Raney S Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
7. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095 [TBL] [Abstract][Full Text] [Related]
8. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1. Ohlsson H; Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1998 Oct; 58(19):4264-8. PubMed ID: 9766649 [TBL] [Abstract][Full Text] [Related]
9. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Zhang QX; Borg A; Fuqua SA Cancer Res; 1993 Dec; 53(24):5882-4. PubMed ID: 8261397 [TBL] [Abstract][Full Text] [Related]
10. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Pfeffer U; Fecarotta E; Vidali G Cancer Res; 1995 May; 55(10):2158-65. PubMed ID: 7743517 [TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Karnik PS; Kulkarni S; Liu XP; Budd GT; Bukowski RM Cancer Res; 1994 Jan; 54(2):349-53. PubMed ID: 8275466 [TBL] [Abstract][Full Text] [Related]
12. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines. Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701 [TBL] [Abstract][Full Text] [Related]
13. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation. King ML; Adler SR; Murphy LL Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429 [TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729 [TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
16. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Kawai H; Li H; Chun P; Avraham S; Avraham HK Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015 [TBL] [Abstract][Full Text] [Related]
17. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045 [TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053 [TBL] [Abstract][Full Text] [Related]
19. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma. Chan CM; Dowsett M J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245 [TBL] [Abstract][Full Text] [Related]
20. Expression of an estrogen receptor variant lacking exon 3 in derivatives of MCF-7 cells with acquired estrogen independence or tamoxifen resistance. Han F; Miksicek R; Clarke R; Conrad SE J Mol Endocrinol; 2004 Jun; 32(3):935-45. PubMed ID: 15171723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]